BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jo HJ, Lee HS, Kim N, Nam RH, Chang H, Kim MS, Kim SE, Oh JC, Lee DH, Jung HC. Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea. J Neurogastroenterol Motil 2013;19:210-8. [PMID: 23667752 DOI: 10.5056/jnm.2013.19.2.210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Kim N. Sex Difference of Esophageal Cancer: Esophageal Squamous Cell Carcinoma vs. Esophageal Adenocarcinoma. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 2022. [DOI: 10.1007/978-981-19-0120-1_6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kim SE, Kim N, Oh S, Kim HM, Park MI, Lee DH, Jung HC. Predictive factors of response to proton pump inhibitors in korean patients with gastroesophageal reflux disease. J Neurogastroenterol Motil 2015;21:69-77. [PMID: 25537676 DOI: 10.5056/jnm14078] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
3 Brown CS, Lapin B, Wang C, Goldstein JL, Linn JG, Denham W, Haggerty SP, Talamonti MS, Howington JA, Carbray J. Predicting regression of Barrett’s esophagus: results from a retrospective cohort of 1342 patients. Surg Endosc. 2014;28:2803-2807. [PMID: 24789137 DOI: 10.1007/s00464-014-3548-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Streher LA, Campos V, Mazzini GDS, Binato M, Meurer L, Edelweiss MI, Gurski RR. CDX2 Overexpression in Barrett’s Esophagus and Esophageal Adenocarcinoma. JCT 2014;05:657-663. [DOI: 10.4236/jct.2014.57074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]